Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells - PubMed (original) (raw)
. 2003 Jan 1;63(1):196-206.
Affiliations
- PMID: 12517798
Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells
M Jane Arboleda et al. Cancer Res. 2003.
Abstract
To determine how AKT2 might contribute to tumor cell progression, a full-length, wild-type, human AKT2/protein kinase B (PKB)beta cDNA was transfected into a panel of eight human breast and ovarian cancer cells. AKT2 transfectants demonstrated increased adhesion and invasion through collagen IV because of up-regulation of beta1 integrins. In addition, AKT2 cells were more metastatic than control cells in vivo. Increased invasion by AKT2 was blocked by preincubation with an anti-beta1 integrin function blocking antibody, exposure to wortmannin, and by expression of phosphatase and tensin homologue tumor suppressor (PTEN). Confocal microscopy performed on transfected human breast cancer cells showed that unlike AKT1, AKT2 protein predominantly localized adjacent to the collagen IV matrix during cellular attachment. Overexpression of AKT2, but not AKT1 or AKT3, was sufficient to duplicate the invasive effects of phosphoinositide 3-OH kinase (PI3-K) transfected in breast cancer cells. Furthermore, expression of kinase dead AKT2(181 amino acid methionine [M]), and not kinase dead AKT1(179M) or AKT3(177M), was capable of blocking invasion induced by either human epidermal growth factor receptor-2 (HER-2) overexpression or by activation of PI3-K. Taken together, these data indicate that AKT2 mediates PI3-K-dependent effects on adhesion, motility, invasion, and metastasis in vivo.
Similar articles
- Akt2: a role in breast cancer metastasis.
Chau NM, Ashcroft M. Chau NM, et al. Breast Cancer Res. 2004;6(1):55-7. doi: 10.1186/bcr739. Epub 2003 Nov 4. Breast Cancer Res. 2004. PMID: 14680486 Free PMC article. - Integrin β1 mediates epithelial growth factor-induced invasion in human ovarian cancer cells.
Lau MT, So WK, Leung PC. Lau MT, et al. Cancer Lett. 2012 Jul 28;320(2):198-204. doi: 10.1016/j.canlet.2012.02.028. Epub 2012 Mar 1. Cancer Lett. 2012. PMID: 22388103 - AKT2, a member of the protein kinase B family, is activated by growth factors, v-Ha-ras, and v-src through phosphatidylinositol 3-kinase in human ovarian epithelial cancer cells.
Liu AX, Testa JR, Hamilton TC, Jove R, Nicosia SV, Cheng JQ. Liu AX, et al. Cancer Res. 1998 Jul 15;58(14):2973-7. Cancer Res. 1998. PMID: 9679957 - Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression.
Das R, Philip S, Mahabeleshwar GH, Bulbule A, Kundu GC. Das R, et al. IUBMB Life. 2005 Jun;57(6):441-7. doi: 10.1080/15216540500159424. IUBMB Life. 2005. PMID: 16012053 Review. - Distinct functions of AKT isoforms in breast cancer: a comprehensive review.
Hinz N, Jücker M. Hinz N, et al. Cell Commun Signal. 2019 Nov 21;17(1):154. doi: 10.1186/s12964-019-0450-3. Cell Commun Signal. 2019. PMID: 31752925 Free PMC article. Review.
Cited by
- Beclin 1 regulates growth factor receptor signaling in breast cancer.
Rohatgi RA, Janusis J, Leonard D, Bellvé KD, Fogarty KE, Baehrecke EH, Corvera S, Shaw LM. Rohatgi RA, et al. Oncogene. 2015 Oct 16;34(42):5352-62. doi: 10.1038/onc.2014.454. Epub 2015 Feb 2. Oncogene. 2015. PMID: 25639875 Free PMC article. - Pleckstrin homology domain-interacting protein (PHIP) as a marker and mediator of melanoma metastasis.
De Semir D, Nosrati M, Bezrookove V, Dar AA, Federman S, Bienvenu G, Venna S, Rangel J, Climent J, Meyer Tamgüney TM, Thummala S, Tong S, Leong SP, Haqq C, Billings P, Miller JR 3rd, Sagebiel RW, Debs R, Kashani-Sabet M. De Semir D, et al. Proc Natl Acad Sci U S A. 2012 May 1;109(18):7067-72. doi: 10.1073/pnas.1119949109. Epub 2012 Apr 17. Proc Natl Acad Sci U S A. 2012. PMID: 22511720 Free PMC article. - Regulation of MicroRNA-497-Targeting AKT2 Influences Tumor Growth and Chemoresistance to Cisplatin in Lung Cancer.
Wang L, Ji XB, Wang LH, Qiu JG, Zhou FM, Liu WJ, Wan DD, Lin MC, Liu LZ, Zhang JY, Jiang BH. Wang L, et al. Front Cell Dev Biol. 2020 Sep 8;8:840. doi: 10.3389/fcell.2020.00840. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 33015042 Free PMC article. - MicroRNAs Involved in Metastasis of Hepatocellular Carcinoma: Target Candidates, Functionality and Efficacy in Animal Models and Prognostic Relevance.
Weidle UH, Schmid D, Birzele F, Brinkmann U. Weidle UH, et al. Cancer Genomics Proteomics. 2020 Jan-Feb;17(1):1-21. doi: 10.21873/cgp.20163. Cancer Genomics Proteomics. 2020. PMID: 31882547 Free PMC article. Review. - Increased incidence of well-differentiated thyroid cancer associated with Hashimoto thyroiditis and the role of the PI3k/Akt pathway.
Larson SD, Jackson LN, Riall TS, Uchida T, Thomas RP, Qiu S, Evers BM. Larson SD, et al. J Am Coll Surg. 2007 May;204(5):764-73; discussion 773-5. doi: 10.1016/j.jamcollsurg.2006.12.037. Epub 2007 Feb 23. J Am Coll Surg. 2007. PMID: 17481480 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous